Non-ownership Filings
Total Voting Rights | Sep. 02, 2024 |
Imfinzi approved in US for resectable lung cancer | Aug. 16, 2024 |
Total Voting Rights | Aug. 01, 2024 |
AstraZeneca prices a €1.4bn bond offering | Jul. 30, 2024 |
Calquence fixed-duration combo improved 1L CLL PFS | Jul. 29, 2024 |
ODAC reviewed Imfinzi in resectable lung cancer | Jul. 26, 2024 |
Half-year Report | Jul. 25, 2024 |
Ownership Update Filings
Director/PDMR Shareholding | Jun. 12, 2024 |
Director/PDMR Shareholding | May. 15, 2024 |
Director/PDMR Shareholding | Mar. 12, 2024 |
Director/PDMR Shareholding | Mar. 06, 2024 |
Director/PDMR Shareholding | Mar. 06, 2024 |
Director/PDMR Shareholding | Feb. 22, 2024 |
Director/PDMR Shareholding | Dec. 14, 2023 |